Gelomics Pty Ltd
- Biotech or pharma, therapeutic R&D
- CMO, CRO
- Other products or services
- Other R&D services
- Biotech or pharma, animal health
Gelomics is an Australian deep-tech biotechnology company revolutionising drug development by replacing animal testing with human-relevant 3D cell culture technologies integrated into an AI-powered platform. Founded in 2018 and headquartered in Brisbane, Gelomics designs and manufactures cutting-edge platforms that enable the growth of functional human tissue models in vitro. Our integrated LunaX System, combining proprietary hydrogels, advanced photopolymerisation devices, and AI-driven software, empowers pharmaceutical and research institutions worldwide to develop safer, more effective therapies, faster.
As KPMG Tech Innovator 2024 in Australia, Gelomics rapidly expanded to over 23 international markets across North America, Europe, Asia-Pacific, and the Middle East, with clients including leading academic institutions, CROs, and multinational pharmaceutical companies. Our mission is to accelerate life science innovation through ethical, scalable, and predictive non-animal models.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}